# ZEISS debuts DORC EVA NEXUS for cataract surgery at ESCRS

- Link: https://www.thailand-business-news.com/pr-news/zeiss-debuts-dorc-eva-nexus-for-cataract-surgery-at-escrs
- Published: 2026-08-27T20:03:00+07:00
- Author: PR Newswire

|   |

Now spanning ZEISS Retina and Cataract Workflows, the EVA NEXUS^(™) ophthalmic surgical
system from ZEISS comes in a cataract-only configuration, bringing a tailored approach
to different surgical needs.

JENA, Germany, Aug. 27, 2026 /PRNewswire/ — | Carl Zeiss Meditec AG

 [⌊The EVA NEXUS™ ophthalmic surgical system from ZEISS in a cataract-only configuration.⌉](https://mmx.prnasia.com/media/MS1976718/DORC-EVA-NEXUS-CATARACT.jpg?id=OA2915730&p=medium600)

The EVA NEXUS™ ophthalmic surgical system from ZEISS in a cataract-only configuration.

ZEISS Medical Technology, one of the world’s leading medical technology companies,
today announced the availability of the [EVA NEXUS^(™) ophthalmic surgical system from ZEISS](https://edge.prnewswire.com/c/link/?t=0&l=en&o=4760858-1&h=145410728&u=https%3A%2F%2Fwww.zeiss.com%2Fmeditec%2Fen%2Fnews-events%2Fevents%2Fescrs-2026.html&a=EVA+NEXUS%E2%84%A2%C2%A0ophthalmic+surgical+system+from+ZEISS)
in a dedicated cataract configuration. The trusted DORC EVA NEXUS technology is 
expanded and designed to offer cataract surgeons streamlined performance, stability
and control in the OR. The newly configured solution will make its global debut 
at the [European Society of Cataract and Refractive Surgeons (ESCRS) congress](https://edge.prnewswire.com/c/link/?t=0&l=en&o=4760858-1&h=373623751&u=https%3A%2F%2Fwww.zeiss.com%2Fmeditec%2Fen%2Fnews-events%2Fevents%2Fescrs-2026.html&a=European+Society+of+Cataract+and+Refractive+Surgeons+(ESCRS)+congress)
in London.

Designed for cataract surgeons, the DORC EVA NEXUS cataract configuration comes 
with a cataract grade selection feature^(1) with up to four programmable pre-sets
allowing surgeons to select optimized phaco, aspiration, and irrigation settings
for a more tailored approach to each surgical step and cataract grade with seamless
activation via footswitch or screen. The solution also aims to support integration
with the ZEISS Cataract Workflow. The DORC EVA NEXUS from ZEISS in a cataract-only
configuration will be available first in select European countries beginning in 
September 2026, followed by global availability pending regional regulatory approvals.

"With the newly configured DORC EVA NEXUS cataract solution, ZEISS’ advanced technology
is redefining how cataract surgeons can operate in the OR – designed for streamlined
performance, stability and control – supporting surgical decisions and procedural
precision," says Dr. Dominik Beck, Head of Posterior Surgery Business Sector at 
ZEISS Medical Technology.

"Having relied on its predecessor, DORC EVA, in my cataract surgery cases for more
than a decade, I recently began using DORC EVA NEXUS, the latest generation of the
platform, and have already experienced the benefits of its innovations in my everyday
surgical practice. DORC EVA NEXUS benefits everyone in the operating room; my staff
and I feel more in control during surgery, which contributes to an improved patient
experience and surgical outcomes," says Dr. Marcus Drodofsky, cataract surgeon, 
Augenärzte Osnabrück (Germany).

Now integrated into the ZEISS Cataract Workflow portfolio, the DORC EVA NEXUS solution
in a cataract-only configuration offers a combination of advanced technology – the
VacuFlow VTi pump, SMART IOP^(™), and EVA EQUIPHACO^(™).

**Performance:** The DORC EVA NEXUS for cataract includes VacuFlow VTi, an advanced
fluidics technology powered by Valve Timing Intelligence, to deliver precise, pulsation‑
free flow or fast, responsive vacuum, providing surgeons with improved efficiency
and control throughout cataract procedures.^(2)

**Stability:** Unique to DORC EVA NEXUS, SMART IOP^(™) automatically compensates
for pressure losses to maintain constant intraocular pressure. It delivers more 
stable, lower anterior chamber pressure and up to 73% higher responsiveness – even
during post‑occlusion breaks.^( 2) 

**Control:** The compact, lightweight DORC EVA SURE TOUCH phaco handpiece together
with the DORC EVA EQUIPHACO full range of high-performance phaco tips, with fitted
color-coded sleeves makes the DORC EVA NEXUS for cataract designed for superior 
chamber stability and ultrasound efficiency, giving surgeons refined phaco control.
The wireless Dual Linear footswitch, customizable and programmable, allows for independent
control of aspiration and ultrasound.^(3)

For more information about the DORC EVA NEXUS from ZEISS in a cataract-only configuration,
visit the ZEISS booth C.100 in the South Event Hall at the [European Society of Cataract and Refractive Surgeons (ESCRS) congress](https://edge.prnewswire.com/c/link/?t=0&l=en&o=4760858-1&h=373623751&u=https%3A%2F%2Fwww.zeiss.com%2Fmeditec%2Fen%2Fnews-events%2Fevents%2Fescrs-2026.html&a=European+Society+of+Cataract+and+Refractive+Surgeons+(ESCRS)+congress)
in London, or visit [www.zeiss.com/med](https://edge.prnewswire.com/c/link/?t=0&l=en&o=4760858-1&h=3136538292&u=http%3A%2F%2Fwww.zeiss.com%2Fmed&a=www.zeiss.com%2Fmed).

_^(1)_ _Availability of this feature may vary by market and is subject to local 
regulatory approvals.^(2)Compared to the DORC EVA Surgical System.^(3)Compared to
the previous design of the DORC phaco handpiece.

_Not all products, services or offers are approved or offered in every market and
approved labeling and instructions may vary from one country to another. For country-
specific product information, see the appropriate country website. Product specifications
are subject to change in design and scope of delivery as a result of ongoing technical
development. The statements of the healthcare professionals reflect only their personal
opinions and experiences and do not necessarily reflect the opinion of any institution
that they are affiliated with. The healthcare professionals alone are responsible
for the content of their experience reported and any potential resulting infringements.
Carl Zeiss Meditec AG and its affiliates do not have clinical evidence supporting
the opinions and statements of the health care professionals nor accept any responsibility
or liability of the healthcare professionals’ content._ _The healthcare professionals
have a contractual or other financial relationship with Carl Zeiss Meditec AG and
its affiliates and have received financial support._

**Contact for investors:Sebastian Frericks
Director Investor RelationsCarl Zeiss
Meditec AGPhone: +49 3641 220 116Mail: [investors.med@zeiss.com](https://www.thailand-business-news.com/pr-news/investors.med@zeiss.com)

**Contact for the press:Frank Smith
Head of Global Communications Ophthalmology,
Carl Zeiss Meditec Inc.Phone: +49 3641 220 331Mail: [press.med@zeiss.com](https://www.thailand-business-news.com/pr-news/press.med@zeiss.com)

Brief Profile

Carl Zeiss Meditec AG (ISIN: DE0005313704), which is listed on the TecDAX and SDAX
of the German stock exchange, is one of the world’s leading medical technology companies.
The Company supplies innovative technologies and application-oriented solutions 
designed to help doctors improve the quality of life of their patients. The Company
offers complete solutions, including implants and consumables, to diagnose and treat
eye diseases. The Company creates innovative visualization solutions in the field
of microsurgery. With 5,784 employees worldwide, the Group generated revenue of 
€2,228m in fiscal year 2024/25 (to 30 September).

The Group’s head office is located in Jena, Germany, and it has subsidiaries in 
Germany and abroad; more than 50 percent of its employees are based in the USA, 
Japan, Spain and France. The Center for Application and Research (CARIn) in Bangalore,
India and the Carl Zeiss Innovations Center for Research and Development in Shanghai,
China, strengthen the Company’s presence in these rapidly developing economies. 
Around 39 percent of Carl Zeiss Meditec AG’s shares are in free float. Approx. 59
percent are held by Carl Zeiss AG, one of the world’s leading groups in the optical
and optoelectronic industries.

For further information visit: [www.zeiss.com/med](https://edge.prnewswire.com/c/link/?t=0&l=en&o=4760858-1&h=3136538292&u=http%3A%2F%2Fwww.zeiss.com%2Fmed&a=www.zeiss.com%2Fmed)

 

---

  |  This article was produced by Cision PR Newswire, our trusted news partner. The views expressed and the content presented here are solely those of the author and may not fully reflect the opinions of Thailand Business News. |

---

 
**Read the original article :** [ZEISS debuts DORC EVA NEXUS for cataract surgery at ESCRS ](http://www.prnasia.com/story/archive/5035007_AE35007_0?rand=184833)